Artivion - Business Information

Manufacturing · Georgia, United States · 1,300 Employees

Artivion is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Artivion was founded in 1984 and is headquartered in Kennesaw, Georgia.Read More

View Company Info for Free

Who is Artivion

Headquarters

1655 Roberts Blvd NW, Kennesaw, Georgia, 30144, United States

Phone Number

(770) 419-3355

Website

www.artivion.com

Revenue

$305M

Industry

Medical Devices & Equipment

Manufacturing

Is this data correct?

View contact profiles from Artivion

Popular SearchesArtivionArtivion IncJOTEC GmbHArtivion APACArtivion EMEASIC Code 38,384NAICS Code 33,339Show More

Artivion Org Chart

View Artivion org chart to access information on key employees and get valuable insights about Artivion organizational structure. The organizational chart highlights the reporting lines within the company, starting with Pat Mackin - the Chairman, President & Chief Executive Officer of Artivion, and followed by additional decision makers: Ashley Lee, Executive Vice President & Chief Operating Officer & Chief Financial Officer, and more..

Pat Mackin

Chairman, President & Chief ...

Phone

Ashley Lee

Executive Vice President & C...

Phone

View Email Formats for Artivion

Artivion Company Metrics

Company Insights

Employee Growth Rate

Acquisitions & Subsidiaries

Jul 18, 2022

Heart Pain Relief

Apr 22, 2018

Ascyrus Medical

On-X Life Technologies

Hemosphere

See More Acquisitions & Subsidiaries

Top Companies in United States

View leading companies in United States by different categories: revenue, number of employees and funding amount. Top companies in United States by revenue is Walmart, by number of employees is Tip Top Poultry and by funding amount is American Airlines. See full lists for all leading companies and additional company information such as contact details, org chart, industry, employees and more.

Artivion News & Media

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
ATLANTA, Sept. 14, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023....
Sep 14, 2023
www.prnewswire.com
Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript
Artivion, Inc. (NYSE:NYSE:AORT) Q2 2023 Earnings Conference Call August 3, 2023 4:30 AM ETCompany ParticipantsLaine Morgan – Gilmartin GroupPat Mackin – Chief Executive OfficerAshley Lee –...
Aug 5, 2023
seekingalpha.com
Artivion Reports Second Quarter 2023 Financial Results
Second Quarter and Recent Business Highlights: Achieved revenue of $89.3 million in the second quarter of 2023 versus $80.3 million in the second quarter of 2022, an increase of 11% on both a GAAP and non-GAAP constant currency basis Net loss was ($3.4) million or ($0.08) per share;...
Aug 3, 2023
www.prnewswire.com
Artivion to Participate in Upcoming Investor Conferences
ATLANTA, Aug. 1, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in three upcoming investor conferences. Artivion's management team will present at the upcoming Canaccord...
Aug 1, 2023
www.prnewswire.com
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results
ATLANTA, July 20, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2023 financial results will be released on Thursday, August 3, 2023 after the market closes. On that day, the...
Jul 20, 2023
www.prnewswire.com